Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare American International Group Inc (AIG) vs Cassava Sciences Inc (FLNA) Price & Performance

American International Group Inc
Cassava Sciences Inc

Price performance

Price movement over the last 24 hours

Key statistics

American International Group Inc vs Cassava Sciences Inc — how do they compare? American International Group Inc trades at $80.31 (market cap $42.98B), while Cassava Sciences Inc trades at $1.33 (market cap $63.04M). The key difference: American International Group Inc is far larger — about 681.8× Cassava Sciences Inc's market cap, and American International Group Inc pays a 2.47% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.

AIGFLNA
Market Cap
$42.98B$63.04M
Sector
FinancialsHealth
52-Week High
$86.59$4.64
52-Week Low
$71.89$1.16
Enterprise Value
$50.68B-$23.53M
Dividend Yield
2.47%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

American International Group Inc

AIG trades at $81.06, up 2.1% today, showing strong momentum with three consecutive quarterly earnings beats. The stock is supported by bullish technical signals and a consensus price target of $88.13. Recent executive appointments and the acquisition of Everest Colombia signal strategic growth initiatives. Revenue stabilized around $26.8B in 2025 with net income margin improving to 11.88%.

Outlook remains positive with earnings growth and expansion in Latin America offering upside potential. Risks include catastrophe exposure and competitive pressures. Analysts are predominantly neutral with 58.5% Hold ratings, suggesting cautious optimism amid solid fundamentals.

Cassava Sciences Inc

FLNA trades at $1.31, up 6.5% today, with a bearish technical signal but recent quarterly earnings beats. The company, focused on therapies for Tuberous Sclerosis Complex-related epilepsy, reported a net loss of $90.97 million in 2025, with negative cash flow from operations. Analyst consensus is bullish with 8 buy ratings out of 12, and recent news highlights business updates and scientific presentations.

The outlook is mixed: strong analyst support and clinical progress offer upside potential, but persistent losses, negative cash flow, and high financial risks pose significant challenges. Investors should weigh the speculative growth prospects against the substantial operational deficits and market volatility.

Returns comparison

Trailing returns across standard periods

About American International Group Inc

American International Group is one of the largest insurance and financial services firms in the world and has a global footprint. It operates through a wide range of subsidiaries that provide property, casualty, and life insurance. Its revenue is split roughly evenly between commercial and consumer lines.

Read more on AIG

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA